Sculptor Capital LP boosted its holdings in LAVA Medtech Acquisition Corp. (NASDAQ:LVAC – Get Rating) by 146.4% during the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 431,160 shares of the company's stock after acquiring an additional 256,158 shares during the period. Sculptor Capital LP owned about 3.00% of LAVA Medtech Acquisition worth $4,303,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of LVAC. Fifth Lane Capital LP bought a new position in LAVA Medtech Acquisition in the fourth quarter worth about $986,000. Radcliffe Capital Management L.P. acquired a new stake in shares of LAVA Medtech Acquisition in the fourth quarter valued at approximately $1,000,000. Starboard Value LP acquired a new stake in shares of LAVA Medtech Acquisition in the fourth quarter valued at approximately $474,000. Saba Capital Management L.P. acquired a new stake in shares of LAVA Medtech Acquisition in the fourth quarter valued at approximately $5,329,000. Finally, Oaktree Capital Management LP acquired a new stake in shares of LAVA Medtech Acquisition in the fourth quarter valued at approximately $2,500,000. Institutional investors own 65.98% of the company's stock.

LAVA Medtech Acquisition Stock Performance

Shares of NASDAQ:LVAC opened at $10.04 on Friday. The firm's 50 day moving average is $10.02 and its two-hundred day moving average is $9.99. LAVA Medtech Acquisition Corp. has a 52 week low of $9.83 and a 52 week high of $10.07.

LAVA Medtech Acquisition Profile

LAVA Medtech Acquisition Corp. does not have significant operations. It intends to acquire assets and businesses through a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization. The company focuses on pursuing opportunities in healthcare and healthcare-related industries.

See Also

• Get a free copy of the StockNews.com research report on LAVA Medtech Acquisition (LVAC)
• Is There a Cure for What is Ailing Teladoc Stock?
• No One Told These 3 Stocks It's a Down Week
• Why Medical Products Maker Repligen May Be A Potential Buy
• At 10%, Is Arbor Realty Trust Dividend Worth It?
• Investors Should Tune Into RF Industries

Want to see what other hedge funds are holding LVAC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LAVA Medtech Acquisition Corp. (NASDAQ:LVAC – Get Rating).

Receive News & Ratings for LAVA Medtech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LAVA Medtech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.